{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:08:57Z","timestamp":1793668137688,"version":"4.5.1"},"reference-count":38,"publisher":"National Academy of Sciences","issue":"24","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"vor","delay-in-days":183,"URL":"http:\/\/www.pnas.org\/site\/aboutpnas\/licenses.xhtml"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["G:0900466"],"award-info":[{"award-number":["G:0900466"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","award":["WT\/204870\/Z\/16\/Z"],"award-info":[{"award-number":["WT\/204870\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union FP7 Marie Curie Action","award":["316655"],"award-info":[{"award-number":["316655"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA 929\/11-1"],"award-info":[{"award-number":["MA 929\/11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2018,6,12]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Conventionally, vaccines are screened for induction of a neutralizing antibody response in human volunteers before proceeding to late-stage clinical trials. We present results from a human cytomegalovirus (HCMV) challenge study suggesting that this paradigm may not apply universally to all viruses. Instead, viruses like HCMV, which establish lifelong infections and grow both cell-free and cell-associated, may be controlled independently of a potent neutralizing antibody response. Our results suggest that more detailed laboratory studies are required to identify correlates of immune protection for such viruses and that failure of a vaccine to induce a neutralizing antibody response should not necessarily be considered as a key go-no-go decision point in the design of future vaccine studies.<\/jats:p>","DOI":"10.1073\/pnas.1800224115","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T15:10:14Z","timestamp":1524496214000},"page":"6273-6278","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":118,"title":["Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies"],"prefix":"10.1073","volume":"115","author":[{"given":"Ilona","family":"Baraniak","sequence":"first","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kropff","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Klinische und Molekulare Virologie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"Ambrose","sequence":"additional","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McIntosh","sequence":"additional","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"McLean","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Immunology Research Centre, London Metropolitan University, London N7 ND8, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Pichon","sequence":"additional","affiliation":[{"name":"Clinical Development, Sanofi Pasteur, 69280 Marcy l\u2019Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S. B.","family":"Milne","sequence":"additional","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mach","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Klinische und Molekulare Virologie, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, 91054 Erlangen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-1076","authenticated-orcid":false,"given":"Matthew B.","family":"Reeves","sequence":"additional","affiliation":[{"name":"Institute for Immunity and Transplantation, University College London, London NW3 2PF, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1086\/527397"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.4437"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/421999"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.135"},{"key":"e_1_3_3_5_2","first-page":"1176","article-title":"Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients","volume":"58","author":"Plotkin SA","year":"1994","unstructured":"SA Plotkin, , Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation 58, 1176\u20131178 (1994).","journal-title":"Transplantation"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804749"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30872-4"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.1.26"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60136-0"},{"key":"e_1_3_3_10_2","first-page":"572","article-title":"VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection","volume":"11","author":"Schleiss MR","year":"2009","unstructured":"MR Schleiss, VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Curr Opin Mol Ther 11, 572\u2013578 (2009).","journal-title":"Curr Opin Mol Ther"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.056"},{"key":"e_1_3_3_12_2","first-page":"85","article-title":"Virus entry and innate immune activation","volume":"325","author":"Isaacson MK","year":"2008","unstructured":"MK Isaacson, LK Juckem, T Compton, Virus entry and innate immune activation. Curr Top Microbiol Immunol 325, 85\u2013100 (2008).","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01251-08"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.5.835"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002172"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-4-979"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.106"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3516"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00435-11"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1704809114"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201574"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy102"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.2.703-710.1993"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri891"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.092"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1404653111"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.07.010"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415310111"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.06.002"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1164376"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006601"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac7732"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113425"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2010.10.031"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243117"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1114966108"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02393-14"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004377"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1800224115","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1800224115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T04:01:08Z","timestamp":1649822468000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1800224115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":38,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018,6,12]]}},"alternative-id":["10.1073\/pnas.1800224115"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1800224115","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"2018-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}